0000950123-24-008730.txt : 20240814 0000950123-24-008730.hdr.sgml : 20240814 20240814160003 ACCESSION NUMBER: 0000950123-24-008730 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 EFFECTIVENESS DATE: 20240814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Fund Management, LLC CENTRAL INDEX KEY: 0001637359 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16844 FILM NUMBER: 241207127 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON ST., SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617 502 6538 MAIL ADDRESS: STREET 1: 888 BOYLSTON ST., SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: Omega Fund Management (US) Inc. DATE OF NAME CHANGE: 20150320 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001637359 XXXXXXXX 06-30-2024 06-30-2024 false Omega Fund Management, LLC
888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
13F HOLDINGS REPORT 028-16844 N
Alexia Pearsall Chief Financial Officer, Omega Fund Management, LLC 617.921.2117 /s/ Alexia Pearsall Boston MA 08-14-2024 0 11 134971971 false
INFORMATION TABLE 2 34511.xml INFORMATION TABLE FOR FORM 13F Alumis Inc Common Stock 022307102 8687893 653225 SH SOLE 653225 0 0 enGene Holdings Inc. Common Stock 29286M105 10150047 1076357 SH SOLE 1076357 0 0 enGene Holdings Inc. Warrant 29286M113 382587 321502 SH SOLE 321502 0 0 Ikena Oncology Common Stock 45175G108 3711053 2249123 SH SOLE 2249123 0 0 Immunic Inc Common Stock 4525EP101 1984858 1788160 SH SOLE 1788160 0 0 Lexeo Therapeutics Common Stock 52886X107 37788700 2355904 SH SOLE 2355904 0 0 Morphic Holding Common Stock 61775R105 5445953 159846 SH SOLE 159846 0 0 Nuvation Bio Common Stock Class A 67080N101 38765581 13275884 SH SOLE 13275884 0 0 Replimune Group Common Stock 76029N106 22151871 2461319 SH SOLE 2461319 0 0 Sana Biotechnology, Inc. Common Stock 799566104 4606875 843750 SH SOLE 843750 0 0 Syros Pharmaceuticals Common Stock 87184Q206 1296553 251270 SH SOLE 251270 0 0